icon-folder.gif   Conference Reports for NATAP  
  64rd Annual Meeting of the
American Association for the
Study of Liver Diseases
Washington, DC Nov 1-5 2013
Back grey_arrow_rt.gif
On-Treatment HCV RNA as a Predictor of Virologic Response in Sofosbuvir-Containing Regimens for Genotype 2/3 HCV Infection: Analysis of the FISSION, POSITRON, and FUSION Studies
  Reported by Jules Levin
AASLD 2013 Nov 1-4 Wash DC
David Wyles,1 David Nelson,2 Mark Swain,3 Robert Gish,1 Ming Lin,4 Shu-Min Chuang,4 Julie Ma,4 John McNally,4 Luisa Stamm,4 Diana Brainard,4 William Symonds,4 John McHutchison,4 David Bernstein,5 Alexander Thompson,6 Alessandra Mangia,7 Ira Jacobson8
1University of California, San Diego, San Diego, CA; 2University of Florida, Gainesville, FL; 3Heritage Medical Research Clinic, Calgary, Alberta, Canada; 4Gilead Sciences, Inc., Foster City, CA; 5North Shore LIJ Health System, Manhasset, NY; 6St. Vincent's Hospital, Fitzroy, Victoria, Australia; 7Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo, Italy; 8Cornell University School of Medicine, New York, NY